2005
DOI: 10.1007/s00431-005-0031-x
|View full text |Cite
|
Sign up to set email alerts
|

Lethal proliferation of erythroid precursors in a neonate with a germline PTPN11 mutation

Abstract: We report a neonate with hypertrophic cardiomyopathy and lethal myeloproliferative disorder with excessively proliferating immature erythroid precursors infiltrating non-hematopoietic organs. Mutational analysis uncovered a germline mutation in the Noonan syndrome/LEOPARD syndrome (NS/LS) gene PTPN11. In conclusion, this case report suggests that congenital myeloproliferative disorders in association with germline PTPN11 mutations may affect the erythroid lineage.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2009
2009
2020
2020

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(9 citation statements)
references
References 30 publications
0
9
0
Order By: Relevance
“…The c.1492C > T variant is located in exon 13 which is a hot spot region for this gene. This variant has previously been reported in individuals with LEOPARD syndrome with variable phenotypic features including multiple lentigines, hypertrophic cardiomyopathy, dysmorphic facial features and variable degree of cognitive deficits (Table 3)1314151634.…”
Section: Discussionmentioning
confidence: 79%
See 1 more Smart Citation
“…The c.1492C > T variant is located in exon 13 which is a hot spot region for this gene. This variant has previously been reported in individuals with LEOPARD syndrome with variable phenotypic features including multiple lentigines, hypertrophic cardiomyopathy, dysmorphic facial features and variable degree of cognitive deficits (Table 3)1314151634.…”
Section: Discussionmentioning
confidence: 79%
“…We detected heterozygous pathogenic variants in five different SHL genes that can explain HL in five (4.9%) Turkish families (Table 1). The pathogenic variants MITF (MIM 156845) c.328C > T78 (Waardenburg syndrome type II; MIM 193510), SOX10 (Kallmann syndrome) c.481C > T9, CHD7 (MIM 608892) c.5050G > A9101112 (CHARGE syndrome; MIM 214800 and Kallmann syndrome; MIM 612370), PTPN11 (MIM 176876) c.1492C > T13141516 (LEOPARD syndrome; MIM 151100), and KMT2D (MIM 602113) c.13259G > A17 (Kabuki syndrome; MIM 147920) had all been previously reported in patients with syndromic findings. All the identified variants were confirmed with Sanger sequencing in probands and tested for in available family members (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…Most cases resolve spontaneously, but fatal progressive disease has been reported in 3 patients (10% of approximately 30 patients reported) [11,15,16]. Progression to AML occurred in 1 patient at 2 years of age [9].…”
Section: Juvenile Myelomonocytic Leukemiamentioning
confidence: 99%
“…These observations may account for this apparent contradiction of having both HCM and JMML due to p.Thr42Ala mutation in PTPN11 . To the best of our knowledge, two neonates with NS presenting with co‐occurrence of HCM and MPD with p.Thr73Ile and p.Arg498Trp mutations have been reported in the literature 18, 19. However, the co‐occurrence of HCM and JMML in neonates with NS with p.Thr42Ala has not been reported before.…”
Section: Discussionmentioning
confidence: 87%
“…So far, only two neonates with NS presenting with concurrent HCM and MPD with p.Thr73Ile and p.Arg498Trp have been reported in the literature 18, 19. Furthermore, the co‐occurrence of HCM and JMML in patients with NS leading to premature death has never been reported before.…”
Section: Introductionmentioning
confidence: 99%